LORI CAPPELLO: Open Payments
NPI 1164076840 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,416 in 52 payments from 20 companies in 2025. Trend: 2023 $608 · 2024 $454 · 2025 $1,416
Food & beverage: $1,416
| Company | Payments | Amount |
|---|---|---|
| Novocure Inc. | 3 | $349 |
| Telix Pharmaceuticals | 2 | $184 |
| Novartis Pharmaceuticals Corporation | 7 | $153 |
| Incyte Corporation | 4 | $77 |
| Eisai Inc. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| ABBVIE INC. | 4 | $66 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| Agios Pharmaceuticals, Inc. | 3 | $51 |
| Janssen Biotech, Inc. | 3 | $50 |
Products named: Optune Gio, ILLUCCIX, LUTATHERA, JAKAFI, Lenvima, KEYTRUDA, PYRUKYND, RYBREVANT.
Industry payments across NJ — which companies pay providers there.
